OPN-TEAD

Publication

Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models

https://www.nature.com/articles/s41467-025-64682-7
Poster

OPN-9840, a non-covalent potent pan-TEAD inhibitor, exhibits single agent efficacy in preclinical malignant mesothelioma models

Download PDF